BR112015012453A8 - métodos e usos para sincronizar o tempo de ovulação e de inseminação em uma leitoa - Google Patents

métodos e usos para sincronizar o tempo de ovulação e de inseminação em uma leitoa

Info

Publication number
BR112015012453A8
BR112015012453A8 BR112015012453A BR112015012453A BR112015012453A8 BR 112015012453 A8 BR112015012453 A8 BR 112015012453A8 BR 112015012453 A BR112015012453 A BR 112015012453A BR 112015012453 A BR112015012453 A BR 112015012453A BR 112015012453 A8 BR112015012453 A8 BR 112015012453A8
Authority
BR
Brazil
Prior art keywords
methods
gilt
insemination
synchronizing
synchronizing ovulation
Prior art date
Application number
BR112015012453A
Other languages
English (en)
Portuguese (pt)
Other versions
BR112015012453A2 (pt
Inventor
E Swanson Mark
e johnston Michael
R Kraeling Robert
Kent Webel Stephen
Original Assignee
Jbs United Animal Health Ii Llc
United Ah Ii Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jbs United Animal Health Ii Llc, United Ah Ii Llc filed Critical Jbs United Animal Health Ii Llc
Publication of BR112015012453A2 publication Critical patent/BR112015012453A2/pt
Publication of BR112015012453A8 publication Critical patent/BR112015012453A8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/108—Swine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Reproductive Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Environmental Sciences (AREA)
  • Fodder In General (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Synchronisation In Digital Transmission Systems (AREA)
BR112015012453A 2012-11-28 2013-11-27 métodos e usos para sincronizar o tempo de ovulação e de inseminação em uma leitoa BR112015012453A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261730763P 2012-11-28 2012-11-28
PCT/US2013/072359 WO2014085674A1 (en) 2012-11-28 2013-11-27 Method for synchronizing time of insemination in gilts

Publications (2)

Publication Number Publication Date
BR112015012453A2 BR112015012453A2 (pt) 2017-07-11
BR112015012453A8 true BR112015012453A8 (pt) 2021-06-29

Family

ID=50828486

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015012453A BR112015012453A8 (pt) 2012-11-28 2013-11-27 métodos e usos para sincronizar o tempo de ovulação e de inseminação em uma leitoa

Country Status (17)

Country Link
US (2) US9724380B2 (https=)
EP (1) EP2925339B1 (https=)
JP (1) JP2016508030A (https=)
KR (1) KR20150095715A (https=)
CN (2) CN113398243A (https=)
AU (1) AU2013352054A1 (https=)
BR (1) BR112015012453A8 (https=)
CA (1) CA2892762C (https=)
CL (1) CL2015001448A1 (https=)
CR (1) CR20150282A (https=)
DK (1) DK2925339T3 (https=)
ES (1) ES2808409T3 (https=)
MX (1) MX367876B (https=)
PH (1) PH12015501187A1 (https=)
RU (1) RU2015125549A (https=)
WO (1) WO2014085674A1 (https=)
ZA (1) ZA201504552B (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1684782E (pt) 2003-10-03 2015-12-21 Thorn Bioscience Llc Processo para a sincronização da ovulação para reprodução regulada sem detecção do cio
RU2568839C2 (ru) 2009-04-23 2015-11-20 ДжейБиЭс Юнайтид Энимал Хэлс II ЛЛК Способ и композиция для синхронизации времени осеменения
DK2925339T3 (da) 2012-11-28 2020-07-20 United Ah Ii Llc Fremgangsmåde til synkronisering af inseminationstidspunkt hos gylte
US20160375090A1 (en) * 2013-11-27 2016-12-29 Jbs United Animal Health Ii Llc Method and composition for synchronizing time of insemination in gilts
CN107173329A (zh) * 2017-07-07 2017-09-19 宣汉县蜀宣花牛养殖专业合作社 一种蜀宣花牛母牛繁殖方法
CN108853484B (zh) * 2018-07-23 2021-08-17 东北农业大学 一种诱导后备母猪同期发情的方法
CN115192693B (zh) * 2021-08-20 2025-08-01 北京市农林科学院 一种诱导母猪同期发情的方法
CN117981715B (zh) 2024-04-07 2024-07-09 中国农业大学 一种促进后备母猪初情期启动和改善发情障碍的后备母猪批次化养殖方法
WO2026048957A1 (ja) * 2024-08-29 2026-03-05 国立大学法人静岡大学 家禽用飼料及び家禽の飼育方法

Family Cites Families (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3860701A (en) 1968-04-22 1975-01-14 Searle & Co Method for use and compositions of 11-lower alkyl steroids and drug delivery system for the controlled elution of 11-lower alkyl steroids
AT347054B (de) 1973-09-29 1978-12-11 Takeda Chemical Industries Ltd Verfahren zur herstellung von neuen nonapeptidamid-derivaten
US4005063A (en) 1973-10-11 1977-01-25 Abbott Laboratories [Des-gly]10 -GnRH nonapeptide anide analogs in position 6 having ovulation-inducing activity
US3991750A (en) 1975-04-28 1976-11-16 Syntex Corporation Dromostanolone propionate implant pellet useful for producing weight gains in animals and suppressing estrus in female animals
SU573159A1 (ru) 1976-03-17 1977-09-25 Всесоюзный Ордена Трудового Красного Знамени Научно-Исследовательский Институт Животноводства Способ синхронизации охоты и овул ции у свиноматок
US4756907A (en) 1978-10-17 1988-07-12 Stolle Research & Development Corp. Active/passive immunization of the internal female reproductive organs
US4732763A (en) 1978-10-17 1988-03-22 Stolle Research And Development Corporation Active/passive immunization of the internal female reproductive organs
JPS5781447A (en) 1980-11-11 1982-05-21 Toyo Jozo Co Ltd Human chorionic gonadotropic hormone c-terminal fragment
GB8428201D0 (en) 1984-11-08 1984-12-19 Glaxo Group Ltd Biological preparations
US4931279A (en) 1985-08-16 1990-06-05 Bausch & Lomb Incorporated Sustained release formulation containing an ion-exchange resin
US4804626A (en) 1986-10-22 1989-02-14 The General Hospital Corporation Immunometric assay for the detection of human chorionic gonadotropin
US4780451B1 (en) 1987-01-23 1995-04-04 Asua International Inc Composition and method for producing superovulation in cattle
US5276022A (en) 1987-09-24 1994-01-04 Jencap Research Ltd. Hormone preparation and method
ATE90570T1 (de) 1988-01-29 1993-07-15 Sumitomo Pharma Verbesserte formulierungen mit kontrollierter abgabe.
US4975280A (en) 1989-01-23 1990-12-04 Ethyl Corporation Bioerodable sustained release implants
FR2663223B1 (fr) 1990-06-14 1994-12-02 Af Aplicaciones Far Lab Forme galenique parenterale.
US5180711A (en) 1990-06-14 1993-01-19 Applied Research Systems Ars Holding N.V. Combined treatment with gnrh antagonist and gnrh to control gonadotropin levels in mammals
US5434136A (en) 1990-12-14 1995-07-18 Mathias; John R. Treatment of motility disorders with a GNRH analog
IE62665B1 (en) 1990-12-17 1995-02-22 Akzo Nv Contraceptive regimen
HU222501B1 (hu) 1991-06-28 2003-07-28 Endorecherche Inc. MPA-t vagy MGA-t tartalmazó nyújtott hatóanyag-felszabadulású gyógyászati készítmény és eljárás előállítására
US5444167A (en) 1993-07-07 1995-08-22 Wallac Oy Variant luteinizing hormone encoding DNA
CA2165802A1 (en) 1993-09-29 1995-04-06 Eun Soo Lee Monoglyceride/lactate ester permeation enhancer for oxybutynin
US5650173A (en) 1993-11-19 1997-07-22 Alkermes Controlled Therapeutics Inc. Ii Preparation of biodegradable microparticles containing a biologically active agent
US5688506A (en) 1994-01-27 1997-11-18 Aphton Corp. Immunogens against gonadotropin releasing hormone
FR2717688B1 (fr) 1994-03-28 1996-07-05 Lhd Lab Hygiene Dietetique Système matriciel transdermique d'administration d'un oestrogène et/ou un progestatif à base d'EVA.
US5747058A (en) 1995-06-07 1998-05-05 Southern Biosystems, Inc. High viscosity liquid controlled delivery system
US5589457A (en) 1995-07-03 1996-12-31 Ausa International, Inc. Process for the synchronization of ovulation
GB9514816D0 (en) 1995-07-19 1995-09-20 Ucli Ltd Substances and their medical use
DK0885002T3 (da) 1996-03-04 2011-08-22 Penn State Res Found Materialer og fremgangsmåder til forøgelse af cellulær internalisering
FR2747042B1 (fr) 1996-04-05 1998-06-05 Besins Iscovesco Lab Medicament a base de progesterone et d'oestradiol
AU2827797A (en) 1996-05-30 1998-01-05 Sepracor, Inc. Nsaids for regulating the reproductive cycle of domesticated animals
US6051558A (en) 1997-05-28 2000-04-18 Southern Biosystems, Inc. Compositions suitable for controlled release of the hormone GnRH and its analogs
US6028057A (en) 1998-02-19 2000-02-22 Thorn Bioscience, Llc Regulation of estrus and ovulation in gilts
FR2776520B1 (fr) 1998-03-25 2000-05-05 Sod Conseils Rech Applic Nouvelles compositions pharmaceutiques destinees a la liberation prolongee de peptides et leur procede de preparation
AU5675099A (en) 1998-08-17 2000-03-06 William E. Trout Use of zeranol to modulate reproductive cycles
AU759016B2 (en) 1998-10-05 2003-04-03 Penn State Research Foundation, The Compositions and methods for enhancing receptor-mediated cellular internalization
WO2000078335A1 (en) 1999-06-18 2000-12-28 Southern Biosystems, Inc. COMPOSITIONS FOR CONTROLLED RELEASE OF THE HORMONE GnRH AND ITS ANALOGS
GB0117057D0 (en) 2001-07-12 2001-09-05 Ferring Bv Pharmaceutical composition
DE602004030546D1 (de) 2003-03-04 2011-01-27 Aspenbio Pharma Inc LH zur Verwendung der Erhaltung einer oder mehreren Schwangerschaften durch Induktion der Bildung des sekundären Gelbkörpers.
MXPA05011299A (es) * 2003-04-30 2006-01-24 Debiopharm Sa Metodos y composiciones utilizando la hormona liberadora de la hormona gonadotropina.
US7456207B2 (en) 2003-09-25 2008-11-25 Teva Pharmaceuticals Usa, Inc. Vaginal pharmaceutical compositions and methods for preparing them
PT1684782E (pt) 2003-10-03 2015-12-21 Thorn Bioscience Llc Processo para a sincronização da ovulação para reprodução regulada sem detecção do cio
FR2865938B1 (fr) 2004-02-05 2006-06-02 Sod Conseils Rech Applic Formulation retard solide comprenant de l'acetate de triptoreline
EP1952162A2 (en) 2005-10-24 2008-08-06 Manawatu Biotech Investments Ltd. (Mbil) Ovulation cycle monitoring and management
US20090036384A1 (en) 2005-12-02 2009-02-05 Parnell Laboratories (Aust) Pty Limited Increasing pregnancy rates
US20070197435A1 (en) * 2006-02-17 2007-08-23 Webel Stephen K Process for the synchronization of ovulation for timed breeding without heat detection
EP1891941A1 (en) 2006-08-11 2008-02-27 OctoPlus Technologies B.V. Aqueous gels comprising microspheres
EP2065032A1 (en) 2007-11-27 2009-06-03 Galderma Research & Development A method for producing adapalene gels
RU2568839C2 (ru) * 2009-04-23 2015-11-20 ДжейБиЭс Юнайтид Энимал Хэлс II ЛЛК Способ и композиция для синхронизации времени осеменения
WO2013119633A1 (en) 2012-02-08 2013-08-15 Dow Corning Corporation Silicone emulsions for delivery of healthcare actives
DK2925339T3 (da) 2012-11-28 2020-07-20 United Ah Ii Llc Fremgangsmåde til synkronisering af inseminationstidspunkt hos gylte
US20160375090A1 (en) 2013-11-27 2016-12-29 Jbs United Animal Health Ii Llc Method and composition for synchronizing time of insemination in gilts
TW201625218A (zh) 2014-04-18 2016-07-16 Ｊｂｓ聯合動物保健有限責任公司 製造含ｇｎｒｈ凝膠之方法

Also Published As

Publication number Publication date
CA2892762A1 (en) 2014-06-05
CL2015001448A1 (es) 2016-01-04
US10376558B2 (en) 2019-08-13
MX367876B (es) 2019-09-10
BR112015012453A2 (pt) 2017-07-11
DK2925339T3 (da) 2020-07-20
EP2925339A1 (en) 2015-10-07
CR20150282A (es) 2015-09-01
CN113398243A (zh) 2021-09-17
PH12015501187A1 (en) 2015-08-10
ES2808409T3 (es) 2021-02-26
US9724380B2 (en) 2017-08-08
CN104994865A (zh) 2015-10-21
RU2015125549A (ru) 2017-01-11
ZA201504552B (en) 2017-11-29
JP2016508030A (ja) 2016-03-17
US20150306169A1 (en) 2015-10-29
EP2925339B1 (en) 2020-04-29
WO2014085674A1 (en) 2014-06-05
EP2925339A4 (en) 2016-08-03
KR20150095715A (ko) 2015-08-21
MX2015006618A (es) 2015-12-16
AU2013352054A1 (en) 2015-06-04
CA2892762C (en) 2022-07-19
US20180133283A1 (en) 2018-05-17

Similar Documents

Publication Publication Date Title
BR112015012453A8 (pt) métodos e usos para sincronizar o tempo de ovulação e de inseminação em uma leitoa
CL2017003258A1 (es) Nuevos derivados hidroxiéster, un proceso para su preparación y composiciones farmacéuticas que los contienen
MX355708B (es) Compuestos de d-aminoacidos para enfermedades del higado.
UY35351A (es) Formulaciones acuosas estables de adalimumab
CL2017000984A1 (es) Reducción de la viscosidad de formulaciones farmacéuticas
GT201400230A (es) Necleòsidos de espìrooxetano de uracilo
CL2015002164A1 (es) Formulación combinada de dos compuesos antivirales.
GT201500233A (es) Derivados de benzotiofeno y composiciones de los mismos como degradantes selectivos de los receptores de estrógeno
UY34697A (es) Métodos para preparar análogos de nucleótidos
MX364229B (es) Composiciones y metodos para tratar enfermedades cardiovasculares.
MX2015007888A (es) Compuestos antivirales.
UY34332A (es) Composiciones y métodos para controlar malezas co mprendiendo un polinucleótido y agente de transfe rencia, y que modulan la fitoeno desaturasa?.
AR077199A1 (es) Composicion farmaceutica y procedimiento de tratamiento para la anticoncepcion de emergencia
BR112012024432A2 (pt) composição farmacêutica de dissolução rápida
CL2018001635A1 (es) Formulaciones y métodos para controlar el ciclo reproductivo y la ovulación.
AR091465A1 (es) Una composicion farmaceutica que contiene acido nicotinico y/o nicotinamida y/o triptofano para influenciar positivamente la microbiota intestinal
BR112017017886A2 (pt) gerando populações de células endoteliais arteriais
BR112015030268A2 (pt) composição farmacêutica, recipiente, kit, e, método para a preparação de uma composição
BR112013015634B8 (pt) composição que compreende gordura, proteína e carboidratos, uso da composição, uso de fibras alimentares, processo para preparação de uma fórmula infantil e processo para preparação da composição
BR112014020113A8 (pt) Composições farmacêuticas e método para diminuir a frequência de micção
PH12015502589A1 (en) 4`-azido, 3`-deoxy-3`-fluoro substituted nucleoside derivatives
CL2011002651A1 (es) Composicion veterinaria que comprende dipropionato de imidocarb, cianocobalamina vitamina b12 y un vehiculo farmaceuticamente aceptable; y su uso para tratar o prevenir enfermedades infecciosas parasitarias en ganado.
AR100028A1 (es) Composiciones nutricionales que contienen ácido estearidónico
MX2016005227A (es) Polipéptidos de acción prolongada y métodos para su producción y administración.
CL2015001368A1 (es) Metodo para anticoncepcion controlada que comprende administrar una preparacion farmaceutica que comprende levonorgestrel y un inhibidor de la cox; uso de la composicion farmaceutica en la anticoncepcion "a la carta".

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06I Publication of requirement cancelled [chapter 6.9 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 6.6.1 NA RPI NO 2462 DE 13/03/2018 POR TER SIDO INDEVIDA.

B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B25D Requested change of name of applicant approved

Owner name: UNITED-AH II, LLC (US)

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]